Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 6 Carcinoma, Non-Small-Cell Lung 2 Urinary Bladder Neoplasms 1 Testicular Neoplasms 1 Surgery 1 Stress, Psychological 1 Stomach Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Seminoma 1 Sarcoma 1 Recurrence 1 Postoperative Complications 1 Parkinson Disease 4, Autosomal Dominant Lewy Body 1 Pancreatic Ductal Adenocarcinoma 1 Ovarian Neoplasms 1 Neoplasms 1 Neoplasm, Residual 1 Neoadjuvant Therapy in Elderly HER2-Positive Breast Cancer 1 Multiple Myeloma 1 Medulloblastoma 1 Lung Neoplasms 1 Liposarcoma 1 Leiomyosarcoma 1 Intermittent Fasting 1 Head and Neck Neoplasms 1 HER2-positive Breast Cancer 1 Esophageal Squamous Cell Carcinoma 1 Carcinoma, Ovarian Epithelial 1 Carcinoma, Intraductal, Noninfiltrating 1 Carcinoma, Hepatocellular 1

Interventions

Specimen Handling 3 Doxorubicin 3 Biopsy 3 Radiotherapy 2 Radiation 2 Magnetic Resonance Spectroscopy 2 Gemcitabine 2 toripalimab 1 talimogene laherparepvec 1 ribociclib 1 peposertib 1 pazopanib 1 liposomal doxorubicin 1 cabozantinib 1 abemaciclib 1 Temozolomide 1 Surgical Procedures, Operative 1 PM 01183 1 Nivolumab 1 Neoadjuvant Therapy 1 Ifosfamide 1 Everolimus 1 Docetaxel 1 ADI PEG20 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Leiomyosarcoma × Neoadjuvant Therapy × 90 days × Clear all

NCT04031677 2026-05-22

STRASS2

European Organisation for Research and Treatment of Cancer - EORTC

Phase 3 Recruiting

Leiomyosarcoma, Liposarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡